Enbrel reverses some AD symptoms

Data from an investigator-sponsored, open-label study of Enbrel etanercept from Amgen (AMGN) in 15 patients with mild to severe Alzheimer's disease (AD) showed that weekly 25-50 mg perispinal injectio...